110 related articles for article (PubMed ID: 9876532)
1. In vivo characteristics of injectable poly(DL-lactic acid) microspheres for long-acting drug delivery.
Kobayashi D; Tsubuku S; Yamanaka H; Asano M; Miyajima M; Yoshida M
Drug Dev Ind Pharm; 1998 Sep; 24(9):819-25. PubMed ID: 9876532
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
Yamakawa I; Tsushima Y; Machida R; Watanabe S
J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728
[TBL] [Abstract][Full Text] [Related]
3. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
[TBL] [Abstract][Full Text] [Related]
4. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of high-content aripiprazole-loaded core-shell structure microsphere for long-release injectable formulation.
Hiraoka S; Uchida S; Namiki N
Chem Pharm Bull (Tokyo); 2014; 62(7):654-60. PubMed ID: 24990503
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
Lalla JK; Sapna K
J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
Hyon SH
Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
[TBL] [Abstract][Full Text] [Related]
8. [A basic study on usefulness of bleomycin incorporated in poly DL-lactic acid].
Kumanohoso T; Natsugoe S; Shimada M; Sagara M; Aikou T; Shimazu H; Shinkawa T; Nakamura K; Fukuzaki H
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1572-4. PubMed ID: 7690536
[TBL] [Abstract][Full Text] [Related]
9. [Intravitreal drug delivery by microspheres of biodegradable polymers].
Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
[TBL] [Abstract][Full Text] [Related]
10. Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres.
Urata T; Arimori K; Nakano H
J Control Release; 1999 Mar; 58(2):133-41. PubMed ID: 10053186
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of oil-in-water type poly (D,L-lactic acid) microspheres containing testosterone enanthate.
Tsubuku S; Sugawara S; Miyajima M; Yoshida M; Asano M; Okabe K; Kobayashi D; Yamanaka H
Drug Dev Ind Pharm; 1998 Oct; 24(10):927-34. PubMed ID: 9876547
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
[TBL] [Abstract][Full Text] [Related]
13. Development of implant tablet for a week-long sustained release.
Takahashi M; Onishi H; Machida Y
J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
Pagar KP; Vavia PR
Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of injectable Mitoxantrone poly (lactic acid)/fullerene implants for in vivo chemo-photodynamic therapy.
Li Z; Zhang FL; Pan LL; Zhu XL; Zhang ZZ
J Photochem Photobiol B; 2015 Aug; 149():51-7. PubMed ID: 26046749
[TBL] [Abstract][Full Text] [Related]
16. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
[TBL] [Abstract][Full Text] [Related]
17. Composite microparticles with in vivo reduction of the burst release effect.
Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P
Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
[TBL] [Abstract][Full Text] [Related]
19. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
